AN UNBIASED VIEW OF LINK ALTERNATIF MBL77

Not all sufferers with CLL demand therapy. Regardless of all the latest advancements, the iwCLL even now recommends watchful observation for clients with asymptomatic condition.86 This advice relies on at least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,